Skip to main content

Table 2 Anti-Tat, anti-Env and anti-Gag antibody responses.

From: The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study

 

High anti-Tat Ab titers

Low anti-Tat Ab titers

No anti-Tat Ab

(n = 11)

(n = 9)

(n = 41)

Anti-Tat Ab-positive (n, %)

   

IgM and IgG positive

3 (27%)

0 (0%)

0 (0%)

IgG and IgA positive

1 (9%)

0 (0%)

0 (0%)

IgM positive

0 (0%)

6 (67%)

0 (0%)

IgG positive

6 (55%)

3 (33%)

0 (0%)

IgA positive

1 (9%)

0 (0%)

0 (0%)

Anti-Env Ab-positive (n, %)

11 (100%)

9 (100%)

41 (100%)

Anti-Gag Ab-positive (n, %)

11 (100%)

9 (100%)

41 (100%)

Median titers (range)

   

IgM anti-Tat

25 (25–25)

25 (25–25)

<25

IgG anti-Tat

600 (200–12800)

100 (100–100)

<100

IgA anti-Tat

100 (25–200)

<25

<25

IgG anti-Env

12,800 (800–51,200)

3,200 (400–12,800)

6,400 (800–38,400)

IgG anti-Gag

102,400 (4,000-2,457,600)

12,800 (1,600-819,200)

19,200 (200–3,276,800)